A more recent study involving a transgenic mouse model overexpressing another known HCC-related oncogene, c-Met, demonstrated that hepatic tumors from these mice most relate to patient HCC tumors with activated Wnt/β-catenin signaling pathway [45], a trend observed in our Iqgap2−/−mice as well. The gene discussed is MET; the disease is hepatocellular carcinoma.